CRIS Current Research Information System

GIUNCHI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.832
NA - Nord America 3.411
EU - Europa 2.566
AF - Africa 327
SA - Sud America 206
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.353
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.351
CN - Cina 1.279
SG - Singapore 1.259
VN - Vietnam 1.254
IT - Italia 654
DE - Germania 392
GB - Regno Unito 349
HK - Hong Kong 316
SE - Svezia 269
KR - Corea 213
IN - India 181
NL - Olanda 171
FR - Francia 150
BR - Brasile 143
FI - Finlandia 113
RU - Federazione Russa 110
CI - Costa d'Avorio 89
IE - Irlanda 89
JP - Giappone 68
TG - Togo 62
ZA - Sudafrica 57
CH - Svizzera 56
SC - Seychelles 52
JO - Giordania 43
CA - Canada 35
TH - Thailandia 34
UA - Ucraina 34
BG - Bulgaria 33
EE - Estonia 31
NG - Nigeria 29
AR - Argentina 27
PH - Filippine 27
AT - Austria 25
ID - Indonesia 23
PK - Pakistan 23
IQ - Iraq 22
BD - Bangladesh 21
BE - Belgio 21
PL - Polonia 21
MX - Messico 18
TW - Taiwan 14
EG - Egitto 12
ES - Italia 11
TR - Turchia 11
CL - Cile 9
IR - Iran 8
MA - Marocco 7
PY - Paraguay 7
SA - Arabia Saudita 7
LT - Lituania 6
VE - Venezuela 6
AU - Australia 5
AZ - Azerbaigian 5
DZ - Algeria 5
EC - Ecuador 5
KE - Kenya 5
TN - Tunisia 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
LB - Libano 4
AL - Albania 3
BO - Bolivia 3
CO - Colombia 3
GE - Georgia 3
GR - Grecia 3
HR - Croazia 3
MY - Malesia 3
NP - Nepal 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
DK - Danimarca 2
EU - Europa 2
JM - Giamaica 2
LU - Lussemburgo 2
RO - Romania 2
UY - Uruguay 2
CY - Cipro 1
GM - Gambi 1
HU - Ungheria 1
IL - Israele 1
LI - Liechtenstein 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
NA - Namibia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PG - Papua Nuova Guinea 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TO - Tonga 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.353
Salva come PNG Salva come JPEG
Città #
Singapore 898
Ashburn 506
Hefei 430
Hong Kong 295
Ho Chi Minh City 283
Southend 278
Hanoi 273
Chandler 254
Fairfield 228
San Jose 204
Seoul 201
Bologna 179
Beijing 145
Santa Clara 142
Houston 108
Seattle 104
Wilmington 99
Los Angeles 92
Woodbridge 90
Abidjan 89
Ann Arbor 89
Dublin 89
Princeton 82
Dallas 81
Boardman 80
Helsinki 79
Cambridge 76
Milan 69
Dong Ket 66
Lomé 62
Lauterbourg 61
New York 53
Tokyo 52
Munich 50
Bern 49
Amman 42
Bengaluru 40
Council Bluffs 39
Da Nang 35
Sofia 33
Bremen 32
Frankfurt am Main 32
Redondo Beach 31
Nanjing 30
Westminster 30
Abeokuta 29
Berlin 29
Krefeld 29
Haiphong 28
Buffalo 26
Padova 26
Turin 25
Johannesburg 23
Brussels 21
Changsha 21
Jinan 21
São Paulo 21
Tongling 21
Falkenstein 20
Biên Hòa 19
Chicago 19
London 19
Bangkok 17
Guangzhou 17
Nuremberg 17
Redmond 17
Saint Petersburg 17
Turku 17
Lappeenranta 16
Rome 16
Jakarta 15
The Dalles 15
Tianjin 15
Shanghai 14
Warsaw 14
Amsterdam 13
Paris 13
San Diego 13
Thái Nguyên 13
Montreal 12
Redwood City 12
Vienna 12
Hangzhou 11
Hải Dương 11
Shenyang 11
Stockholm 11
Toronto 11
Xi'an 11
Florence 10
Medford 10
Naples 10
Orem 10
Thái Bình 10
Hebei 9
Kyiv 9
Quận Bình Thạnh 9
Atlanta 8
Baghdad 8
Boston 8
Cesena 8
Totale 7.147
Salva come PNG Salva come JPEG
Nome #
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer 265
Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging 232
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 231
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 229
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD) 219
Effectiveness of Radiomic ZOT Features in the Automated Discrimination of Oncocytoma from Clear Cell Renal Cancer 217
H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma 215
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 210
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 210
18F-FACBC PET/CT FOR NODAL STAGING IN HIGH RISK PROSTATE CANCER: PRELIMINARY DIAGNOSTIC ACCURACY ANALYSIS 205
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes 195
Fibrotic Adhesive Toxic-fat (F.A.T.): the association of fibrotic and adhesive perirenal fat with peri-operative outcomes of robot-assisted par tial nephrectomy (RAPN) 195
Multiparametric magnetic resonance imaging for the differential diagnosis between granulomatous prostatitis and prostate cancer: a literature review to an intriguing diagnostic challenge 193
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and midterm follow-up 193
Beyond multiparametric MRI and towards radiomics to detect prostate cancer: A machine learning model to predict clinically significant lesions 190
The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players? 190
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations 189
The Use of Augmented Reality to Guide the Intraoperative Frozen Section During Robot-assisted Radical Prostatectomy 186
Incremento dell’attività di RM multiparametrica della prostata: esperienza di un centro a elevato volume di attività 185
A case of prolonged cholestatic hepatitis induced by azithromycin in a young woman 184
Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: Correlations with cholangiocarcinoma aggressiveness 183
Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection 182
The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates 182
Compa rison of 18F-fluciclovine PET/CT with 11 C-Choline PET/CT for nodal staging in prostate cancer: a prospective study 181
[68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial 179
Nodal Occult Metastases in Intermediate- and High-Risk Prostate Cancer Patients Detected Using Serial Section, Immunohistochemistry, and Real-Time Reverse Transcriptase Polymerase Chain Reaction: Prospective Evaluation With Matched-Pair Analysis. 174
Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers. 171
Chromosome 3p gene alterations as biomarkers for immunocombinations in metastatic renal cell carcinoma: A hypothesis-generating analysis 169
Frozen section analysis of unusual small testicular tumor masses: report of 3 cases 166
POSSIAMO INCLUDERE NELLA SORVEGLIANZA ATTIVA PER NEOPLASIA PROSTATICA, PAZIENTI CON CGS 3+4 IN UN UNICO PRELIEVO BIOPTICO? RISULTATI A MEDIO TERMINE DI UN SINGOLO CENTRO DOPO REVISIONE ISTOLOGICA SISTEMATICA DEI PRELIEVI BIOPTICI E DEI REPERTI OPERATORI 163
PI-RADS version 2.1 for the evaluation of transition zone lesions: a practical guide for radiologists 160
The role of MRI in the detection of local recurrence: Added value of multiparametric approach and Signal Intensity/Time Curve analysis 159
Diagnostic performance of MRI/TRUS fusion-guided biopsies vs. systematic prostate biopsies in biopsy-naïve, previous negative biopsy patients and men undergoing active surveillance 159
Incidence, etiology, histologic findings, and courses of thoracic inflammatory aortopathies 158
Mutations of NOTCH Genes as an Alternative Mechanism to Activate mTOR pathway in Low-grade Oncocytic Tumor (LOT) of the Kidney 157
TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis 155
Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer 154
Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach 149
Beyond multiparametric MRI and towards radiomics to detect prostate cancer: A machine learning model to predict clinically significant lesions 148
Primary liver sarcomatous carcinoma: report of two cases and review of the literature. 148
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy 147
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type 147
Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge 144
Revised Gleason Grading System Is a Better Predictor of Indolent Prostate Cancer at the Time of Diagnosis: Retrospective Clinical-Pathological Study on Matched Biopsy and Radical Prostatectomy Specimens. 142
Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients 142
The Tumor Entity Denominated “clear cell-papillary renal cell carcinoma” According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 141
The Role of [18F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [11C]Choline PET/CT and Histopathological Analysis. 141
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT 140
MULTIPLE RENAL ONCOCYTIC TUMORS: HISTOLOGICAL, IMMUNOHISTOCHEMICAL AND CYTO-GENETICAL COMPARATIVE ANALYSIS 140
Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study 140
Site-specific concordance of targeted and systematic biopsy cores at the index lesion on multiparametric magnetic resonance: can we spare the double-tap? 138
Perineural invasion and risk of lethal prostate cancer 137
[18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial 134
Impact of HER2 assessment by CISH in urothelial carcinoma: A retrospective single-center experience 132
Similarities and differences between clear cell tubulo-papillary and conventional clear cell renal cell carcinoma: A comparative phenotypical and mutational analysis 130
Abstracts from USCAP 2020: Genitourinary Pathology (860-1046) HPV Status and World Health Organization 2016 Classification of Penile Squamous Cell Carcinoma and Penile Intraepithelial Neoplasia: 206 Cases from a Single, Contemporary, Western Cohort of Patients with Emphasis on the “Discordant Cases" 127
Emerging Molecular Technologies in Genitourinary Tumors 123
Comparison of prostate cancer detection rate at targeted biopsy of hub and spoke centers mpMRI: experience matters 122
Diagnostic Accuracy of 11C-Choline PET/CT in Preoperative Lymph Node Staging of Bladder Cancer: A Systematic Comparison With Contrast-Enhanced CT and Histologic Findings. 121
Evaluating the performance of clinical and radiological data in predicting prostate cancer in prostate imaging reporting and data system version 2.1 category 3 lesions of the peripheral and the transition zones 119
Role of multiparametric magnetic resonance and ultrasound-guided/MR fusion biopsy in patients with low-risk prostate cancer suitable for active surveillance 116
Unusual Thyroid Carcinoma Metastases: a Case Series and Literature Review 112
Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68Ga-PSMA PET/CT Features in Primary Staging 107
Cohort profile: the Turin prostate cancer prognostication (TPCP) cohort 105
The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors 104
SOX2 and PRAME in the "reprogramming" of seminoma cells 102
First case of bilateral, synchronous anaplastic variant of spermatocytic seminoma treated with radical orchifunicolectomy as single approach: Case report and review of the literature 98
Case Report: Pulmonary Actinomyces Infection Mimics Lung Cancer on [68Ga]Ga-FAPI PET/CT 90
Interobserver agreement of PD-L1 (SP263) assessment in advanced NSCLC on cytological smears and histological samples 90
Immunohistochemical expression of EZH2 in germ cell tumors of the testis: New insights into the genesis and epigenetic reprogramming of these fascinating tumors 89
null 84
Role of PD-L1 assessment in advanced NSCLC: does it still matter? 80
Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencing 73
null 73
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab 69
The new classification of renal cell carcinoma: what is the clinical issue? 37
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 29
Totale 11.595
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.757
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021285 0 0 0 0 0 0 0 0 0 26 27 232
2021/2022845 65 18 30 72 60 35 42 70 38 68 219 128
2022/20231.250 90 168 70 131 116 89 50 61 220 47 89 119
2023/2024687 66 65 44 53 42 95 50 61 108 35 33 35
2024/20252.312 133 244 187 137 240 131 177 96 53 224 211 479
2025/20264.889 633 636 479 431 520 202 601 119 959 309 0 0
Totale 11.595